Differential (Click to cross reference) adverse drug reaction ammonia anticonvulsants, blood level determination of anticonvulsants, mechanism of action of anticonvulsants, untoward effects of ataxia ataxia, cerebellar ataxic gait catechol-o-methyltransferase inhibitor cerebral edema cerebrospinal fluid, gammaglobulin of cerebrospinal fluid, gold sol.curve of coma compliance confusion cop 1 creatine phosphokinase(CPK)elevated cryoglobulinemia deprenyl dilantin, factors influencing metabolism of drowsiness electroencephalogram electroencephalogram, abnormalities of encephalomyelitis, postinfectious enzyme, muscle disease enzyme, serum fasciculation fatigue fever flu-like illness gait disorder headache hepatic encephalopathy hepatic failure hepatitis hepatitis C virus hyperbilirubinemia influenza A virus interferon interferon beta 1-a interferon beta 1-b intracranial pressure monitoring jaundice lactic dehydrogenase(LDH) lethargy leukopenia level of consciousness, decreased liver biopsy liver function enzymes lymphopenia mononeuropathy multiplex mortality multiple sclerosis multiple sclerosis, relapsing multiple sclerosis, treatment of muscle biopsy muscle cramp muscular dystrophy muscular dystrophy, Duchenne nausea and vomiting nerve biopsy nerve conduction studies neuropathy neuropathy, cryoglobulinemic neuropathy, peripheral neuropathy, vasculitic, nonsystemic Parkinson disease Parkinson disease, treatment of patient information and support pericarditis pleocytosis of cerebrospinal fluid polymyositis polyneuropathy pregnancy, neurologic complications in prothrombin time, prolonged review article Reye's syndrome Reye's syndrome, adult Sabin-Feldman dye test sedimentation rate, elevated seizure seizure, treatment of serum glutamic oxaloacetic transaminase serum glutamic pyruvic transaminase sodium valproate sodium valproate, toxicity thrombocytopenia tolcapone toxoplasma complement fixation test toxoplasmosis, acquired toxoplasmosis, CNS treatment of neurologic disorder tremor tremor, intention uveitis viral infection viral infection, CNS weakness weight gain

Showing articles 0 to 11 of 11 Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management The Neurologist 8:227-236, Frohman,E.,et al, 2002 Tasmar (tolcapone) Labeling Revisions of Package Insert Roche Laboratories, , 1998 Nonsystemic Vasculitic Mononeuropathy Multiplex, Cryoglobulinemia, and Hepatitis C Muscle & Nerve 19:1596-1602996., David,W.S.,et al, 1996 Diag of Occult Muscular Dystrophy:"Chance"Finding of Elevated Serum Aminotransferase Act J Pediatr 122:254-256, Morse,R.P.&Rosman,N.P., 1993 Long-Term Efficacy and Safety of Deprenyl (Selegiline) in Advanced Parkinson's Disease Neurol 39:1109-1111, Golbe,L.I.,et al, 1989 Diagnosis & Treatment of Reye's Syndrome JAMA 246:2441-2444, Dodge,P.R.,et al, 1981 Acute Hepatic Failure Associated with the Use of Sodium Valproate NEJM 300:962-966, Suchy,F.J.,et al, 1979 Reye's Syndrome in the Adult Patient Am J Med 67:672-678, Atkins,J.N.,et al, 1979 Valproic Acid, Review of a New Antiepileptic Drug Arch Neurol 36:393-398, Bruni,J.,et al, 1979 Effect of Valproic Acid on Hepatic Function Neurol 28:961-964, Willmore,L.J.,et al, 1978 Adult Toxoplasmosis Presenting as Polymyositis & Cerebellar Ataxia Ann Int Med 82:367, Greenlee,J.,et al, 1975 Showing articles 0 to 11 of 11